JNCE insider filings
Jounce Therapeutics, Inc. — 13 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-05-05. Screen JNCE transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for JNCE between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Jounce Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-05-05 | 4 | Concentra Biosciences, LLC — 10% owner | Other (J): 10,000 @ $9,737.70 | EDGAR |
| 2023-05-05 | 4 | TANG KEVIN C — Director, 10% owner TANG CAPITAL MANAGEMENT LLC — 10% owner TANG CAPITAL PARTNERS LP — 10% owner | Code (U): 5,300,087 @ $1.85 · Other (J): 10,000 @ $9,737.70 | EDGAR |
| 2023-05-04 | 4 | Salter-Cid Luisa — Director | Disposition to issuer (D): 31,400 (derivative) · Disposition to issuer (D): 7,850 (derivative) · Disposition to issuer (D): 20,000 (derivative) | EDGAR |
| 2023-05-04 | 4 | Raythatha Jigar — Director | Disposition to issuer (D): 31,400 (derivative) · Disposition to issuer (D): 20,000 (derivative) | EDGAR |
| 2023-05-04 | 4 | Kamen Robert — Director | Code (U): 60,975 · Code (U): 33,875 · Disposition to issuer (D): 10,840 (derivative) · Disposition to issuer (D): 13,550 (derivative) · Disposition to issuer (D): 15,700 (derivative) · Disposition to issuer (D): 15,700 (derivative) · +2 more | EDGAR |
| 2023-05-04 | 4 | Iannone Robert — Director | Disposition to issuer (D): 31,400 (derivative) · Disposition to issuer (D): 7,850 (derivative) · Disposition to issuer (D): 15,700 (derivative) · Disposition to issuer (D): 20,000 (derivative) | EDGAR |
| 2023-05-04 | 4 | Diaz Luis — Director | Disposition to issuer (D): 27,100 (derivative) · Disposition to issuer (D): 10,163 (derivative) · Disposition to issuer (D): 15,700 (derivative) · Disposition to issuer (D): 15,700 (derivative) · Disposition to issuer (D): 15,700 (derivative) · Disposition to issuer (D): 20,000 (derivative) | EDGAR |
| 2023-05-04 | 4 | Duncan Barbara Gayle — Director | Disposition to issuer (D): 34,271 (derivative) · Disposition to issuer (D): 10,840 (derivative) · Disposition to issuer (D): 13,550 (derivative) · Disposition to issuer (D): 15,700 (derivative) · Disposition to issuer (D): 15,700 (derivative) · Disposition to issuer (D): 15,700 (derivative) · +1 more | EDGAR |
| 2023-05-04 | 4 | Drapkin Kimberlee C — President, CFO and Treasurer | Code (U): 25,751 · Code (U): 40,267 · Disposition to issuer (D): 206,005 (derivative) · Disposition to issuer (D): 8,130 (derivative) · Disposition to issuer (D): 77,235 (derivative) · Disposition to issuer (D): 97,500 (derivative) · +4 more | EDGAR |
| 2023-05-04 | 4 | KARSEN PERRY A — Director | Code (U): 5,000 · Disposition to issuer (D): 75,880 (derivative) · Disposition to issuer (D): 16,260 (derivative) · Disposition to issuer (D): 13,350 (derivative) · Disposition to issuer (D): 15,700 (derivative) · Disposition to issuer (D): 15,700 (derivative) · +2 more | EDGAR |
| 2023-05-04 | 4 | MURRAY RICHARD /CA/ — Director | Code (U): 188,778 · Disposition to issuer (D): 665,169 (derivative) · Disposition to issuer (D): 165,954 (derivative) · Disposition to issuer (D): 54,200 (derivative) · Disposition to issuer (D): 182,926 (derivative) · Disposition to issuer (D): 200,000 (derivative) · +5 more | EDGAR |
| 2023-04-06 | 4 | MURRAY RICHARD /CA/ — Director | Sale (S): 39,228 @ $1.85 | EDGAR |
| 2023-03-14 | 4 | TANG KEVIN C — 10% owner TANG CAPITAL MANAGEMENT LLC — 10% owner TANG CAPITAL PARTNERS LP — 10% owner | Purchase (P): 65,701 @ $0.99 · Purchase (P): 20,286 @ $1.02 | EDGAR |
Recent 8-K events — Jounce Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-05-04 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-03-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-03-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement ? 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-03-15 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-03-13 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-02-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement ? 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=JNCE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →